Public Profile

TerSera Therapeutics LLC

TerSera Therapeutics LLC, a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in developing innovative therapies for patients with unmet medical needs, particularly in the areas of oncology and rare diseases. With a focus on precision medicine, TerSera's core products include advanced therapeutics that leverage cutting-edge research and technology, setting them apart in a competitive market. The company has achieved significant milestones, including strategic partnerships and successful product launches, which have solidified its position as a trusted name in the healthcare sector. TerSera Therapeutics continues to drive advancements in treatment options, demonstrating a commitment to improving patient outcomes and enhancing the quality of life for those they serve.

DitchCarbon Score

How does TerSera Therapeutics LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

TerSera Therapeutics LLC's score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

TerSera Therapeutics LLC's reported carbon emissions

TerSera Therapeutics LLC, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of concrete data, it is essential to note that many companies in the biopharmaceutical sector are increasingly focusing on sustainability and setting ambitious climate goals. However, TerSera's specific initiatives or commitments remain unspecified.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. TerSera Therapeutics LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for TerSera Therapeutics LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

TerSera Therapeutics LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Heron Therapeutics, Inc.

US
Health and social work services (85)
Updated 24 days ago

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Hoffmann-La Roche Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Eisai

JP
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Helsinn Therapeutics (U.S.), Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers